by RxTarget.hu | Apr 16, 2020 | Publications
Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma Lajos Géczi, György Bodoky, György Rokszin, Ibolya Fábián, László Torday (Pathology & Oncology Research,...
by RxTarget.hu | Jan 2, 2020 | Publications
Changes in the incidence and prevalence of type 1 and type 2 diabetes among 2 million children and adolescents in Hungary between 2001 and 2016 – a nationwide population-based study (Arch Med Sci 2020; 16 (1): 34–41) László Barkai, Zoltán Kiss, György Rokszin, Zsolt...
by RxTarget.hu | Oct 23, 2019 | Publications
Frontiers in Oncology Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi,...
by RxTarget.hu | Jul 27, 2019 | Publications
Decreasing incidence of pharmacologically treated Type 2 diabetes in Hungary from 2001 to 2016: A nationwide cohort study György Jermendy, Zoltán Kiss, György Rokszin, Zsolt Abonyi-Tóth, István Wittmann, Péter Kempler (Diabetes Research and Clinical Practice 155...
by RxTarget.hu | Jun 22, 2019 | Publications
Young adult patients with type 1 diabetes have a higher risk of mortality than those of similar age with type 2 diabetes: A nationwide analysis in Hungary Zoltán Kiss, György Rokszin, Zsolt Abonyi‐Tóth, György Jermendy, Péter Kempler, László Barkai, István Wittmann...
